Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1999 Dec;52(12):910–913. doi: 10.1136/jcp.52.12.910

A human skin explant model for predicting graft-versus-host disease following bone marrow transplantation.

L Sviland 1, A M Dickinson 1
PMCID: PMC501659  PMID: 10711254

Abstract

Graft-versus-host disease (GVHD) is the most serious complication following bone marrow transplantation, with an incidence of 40-60%. The disease can be fatal in 50% of cases, even in patients receiving marrow from an HLA identical sibling. Several assays have been developed to try to predict the development of GVHD, including mixed lymphocyte culture reaction, cytotoxic T lymphocyte precursor, and helper T lymphocyte precursor frequency assays. This review describes an in vitro skin explant model which has been used since 1988 for both predicting acute GVHD in HLA identical sibling bone marrow transplantation and studying the pathophysiology of the disease. The model involves sensitising donor lymphocytes in vitro in a primary mixed lymphocyte reaction and then evaluating the secondary response on patient skin biopsies by grading the graft-versus-host reactivity (grades I-IV) histopathologically. From analysis of collective data the model is a clear predictor of GVHD and superior to the other assays widely used, with a correlation of 82% with clinical outcome. The skin explant model allows the investigator to study the pathogenesis of GVHD. The cytokines TNF alpha and IFN gamma are shown to be important mediators of cellular damage in graft-versus-host reactions. Recent work has also involved using the model to study the alloreactivity of cord blood. The model is currently being assessed in several bone marrow transplantation centres in Europe on different patient groups including those who receive marrow from haploidentical and matched unrelated donors.

Full text

PDF
910

Images in this article

911Image
on p.911
911Image
on p.911
911Image
on p.911

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Broxmeyer H. E., Douglas G. W., Hangoc G., Cooper S., Bard J., English D., Arny M., Thomas L., Boyse E. A. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A. 1989 May;86(10):3828–3832. doi: 10.1073/pnas.86.10.3828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Dickinson A. M., Sviland L., Carey P., Reid M. M., Hamilton P. J., Pearson A. J., Proctor S. J. Skin explant culture as a model for cutaneous graft-versus-host disease in humans. Bone Marrow Transplant. 1988 Jul;3(4):323–329. [PubMed] [Google Scholar]
  3. Dickinson A. M., Sviland L., Carey P., Reid M. M., Hamilton P. J., Pearson A. J., Proctor S. J. Skin explant culture as a model for cutaneous graft-versus-host disease in humans. Bone Marrow Transplant. 1988 Jul;3(4):323–329. [PubMed] [Google Scholar]
  4. Dickinson A. M., Sviland L., Dunn J., Carey P., Proctor S. J. Demonstration of direct involvement of cytokines in graft-versus-host reactions using an in vitro human skin explant model. Bone Marrow Transplant. 1991 Mar;7(3):209–216. [PubMed] [Google Scholar]
  5. Dickinson A. M., Sviland L., Hamilton P. J., Usher P., Taylor P., Jackson G., Dunn J., Proctor S. J. Cytokine involvement in predicting clinical graft-versus-host disease in allogeneic bone marrow transplant recipients. Bone Marrow Transplant. 1994 Jan;13(1):65–70. [PubMed] [Google Scholar]
  6. Dickinson A. M., Sviland L., Jackson G., Dunn J., Stephens S., Proctor S. J. Monoclonal anti-TNF-alpha suppresses graft vs host disease reactions in an in vitro human skin model. Cytokine. 1994 Mar;6(2):141–146. doi: 10.1016/1043-4666(94)90035-3. [DOI] [PubMed] [Google Scholar]
  7. Dickinson A. M., Sviland L., Wang X. N., Jackson G., Taylor P. R., Dunn A., Proctor S. J. Predicting graft-versus-host disease in HLA-identical bone marrow transplant: a comparison of T-cell frequency analysis and a human skin explant model. Transplantation. 1998 Oct 15;66(7):857–863. doi: 10.1097/00007890-199810150-00008. [DOI] [PubMed] [Google Scholar]
  8. Heslop H. E., Gottlieb D. J., Bianchi A. C., Meager A., Prentice H. G., Mehta A. B., Hoffbrand A. V., Brenner M. K. In vivo induction of gamma interferon and tumor necrosis factor by interleukin-2 infusion following intensive chemotherapy or autologous marrow transplantation. Blood. 1989 Sep;74(4):1374–1380. [PubMed] [Google Scholar]
  9. Heslop H. E., Gottlieb D. J., Reittie J. E., Bello-Fernandez C., Meager A., Prentice H. G., Brenner M. K. Spontaneous and interleukin 2 induced secretion of tumour necrosis factor and gamma interferon following autologous marrow transplantation or chemotherapy. Br J Haematol. 1989 Jun;72(2):122–126. doi: 10.1111/j.1365-2141.1989.tb07671.x. [DOI] [PubMed] [Google Scholar]
  10. Kaminski E., Hows J., Man S., Brookes P., Mackinnon S., Hughes T., Avakian O., Goldman J. M., Batchelor J. R. Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation. Transplantation. 1989 Oct;48(4):608–613. [PubMed] [Google Scholar]
  11. Kurtzberg J., Laughlin M., Graham M. L., Smith C., Olson J. F., Halperin E. C., Ciocci G., Carrier C., Stevens C. E., Rubinstein P. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med. 1996 Jul 18;335(3):157–166. doi: 10.1056/NEJM199607183350303. [DOI] [PubMed] [Google Scholar]
  12. Körholz D., Hempel L., Packeisen J., Kunst D., Zintl F., Burdach S. Die Bedeutung des Interleukin 10 für die akute Graft versus Host Erkrankung bei Kindern und Jugendlichen nach allogener Knochenmarktransplantation. Klin Padiatr. 1996 Jul-Aug;208(4):141–144. doi: 10.1055/s-2008-1046464. [DOI] [PubMed] [Google Scholar]
  13. Lachance S., Le Gouvello S., Roudot F., Kuentz M., Bernaudin F., Beaujean F., Bierling P., Cordonnier C., Farcet J. P., Vernant J. P. Predictive value of host-specific donor helper T-cell precursor frequency for acute graft-versus-host disease and relapse in HLA-identical siblings receiving allogeneic bone marrow transplantation for hematological malignancies. Transplantation. 1997 Oct 27;64(8):1147–1152. doi: 10.1097/00007890-199710270-00012. [DOI] [PubMed] [Google Scholar]
  14. Lerner K. G., Kao G. F., Storb R., Buckner C. D., Clift R. A., Thomas E. D. Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplant Proc. 1974 Dec;6(4):367–371. [PubMed] [Google Scholar]
  15. Limb G. A., Meager A., Woolley J., Wadhwa M., Biggerstaff J., Brown K. A., Wolstencroft R. A. Release of cytokines during generation of lymphokine-activated killer (LAK) cells by IL-2. Immunology. 1989 Dec;68(4):514–519. [PMC free article] [PubMed] [Google Scholar]
  16. Middleton P. G., Taylor P. R., Jackson G., Proctor S. J., Dickinson A. M. Cytokine gene polymorphisms associating with severe acute graft-versus-host disease in HLA-identical sibling transplants. Blood. 1998 Nov 15;92(10):3943–3948. [PubMed] [Google Scholar]
  17. Nakhleh R. E., Snover D. C., Weisdorf S., Platt J. L. Immunopathology of graft-versus-host disease in the upper gastrointestinal tract. Transplantation. 1989 Jul;48(1):61–65. doi: 10.1097/00007890-198907000-00014. [DOI] [PubMed] [Google Scholar]
  18. Rubinstein P., Carrier C., Scaradavou A., Kurtzberg J., Adamson J., Migliaccio A. R., Berkowitz R. L., Cabbad M., Dobrila N. L., Taylor P. E. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998 Nov 26;339(22):1565–1577. doi: 10.1056/NEJM199811263392201. [DOI] [PubMed] [Google Scholar]
  19. Sviland L., Dickinson A. M., Carey P. J., Pearson A. D., Proctor S. J. An in vitro predictive test for clinical graft-versus-host disease in allogeneic bone marrow transplant recipients. Bone Marrow Transplant. 1990 Feb;5(2):105–109. [PubMed] [Google Scholar]
  20. Theobald M., Nierle T., Bunjes D., Arnold R., Heimpel H. Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings. N Engl J Med. 1992 Dec 3;327(23):1613–1617. doi: 10.1056/NEJM199212033272301. [DOI] [PubMed] [Google Scholar]
  21. Vogelsang G. B., Hess A. D., Berkman A. W., Tutschka P. J., Farmer E. R., Converse P. J., Santos G. W. An in vitro predictive test for graft versus host disease in patients with genotypic HLA-identical bone marrow transplants. N Engl J Med. 1985 Sep 12;313(11):645–650. doi: 10.1056/NEJM198509123131101. [DOI] [PubMed] [Google Scholar]
  22. Wagner J. E., Kernan N. A., Steinbuch M., Broxmeyer H. E., Gluckman E. Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease. Lancet. 1995 Jul 22;346(8969):214–219. doi: 10.1016/s0140-6736(95)91268-1. [DOI] [PubMed] [Google Scholar]
  23. Wang X. N., Sviland L., Ademokun A. J., Dunn J., Cavanagh G., Proctor S. J., Dickinson A. M. Cellular alloreactivity of human cord blood cells detected by T-cell frequency analysis and a human skin explant model. Transplantation. 1998 Oct 15;66(7):903–909. doi: 10.1097/00007890-199810150-00015. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES